Matalon Kimberlee Michals, Acosta Phyllis B, Azen Colleen
Department of Health and Human Performance, University of Houston, Houston, Texas 77204-6020, USA.
Pediatrics. 2003 Dec;112(6 Pt 2):1534-6.
The maternal phenylketonuria (PKU) syndrome is caused by high blood phenylalanine (Phe) levels during pregnancy, leading to a host of birth defects, especially microcephaly and congenital heart disease (CHD). For finding whether the maternal PKU syndrome could be prevented, an international collaborative study was organized to evaluate treatment with a Phe-restricted diet. Blood Phe levels, maternal weight gain, and nutrient intakes during pregnancy were evaluated as to their effect on the rate of microcephaly and CHD in the offspring.
The study was a prospective, longitudinal effort aimed at lowering blood Phe during pregnancy. Women were enrolled at time of referral for pregnancy. Nutrient intake analysis, which serves as the basis for this report, was available from 251 pregnancies. Subjects were stratified by blood Phe control of < or =600 micromol/L by 8 weeks gestation or >600 micromol/L by 8 weeks gestation. Outcome of these pregnancies was correlated to blood Phe levels, weight gain, and nutrient intake.
The study goal was to attain blood Phe levels of 120 to 360 micromol/L 3 months preconception; however, this goal was achieved by only a limited number of patients. Therefore, the data presented were based on blood Phe control < or =600 micromol/L or >600 micromol/L by 8 weeks of gestation. Blood Phe control of < or =600 micromol/L by 8 weeks of gestation was attained by 86 (34.3%) of the 251 women in this study, whereas the other 165 women had blood Phe control >600 micromol/L by 8 weeks of gestation. Of the 251 offspring, 166 were born with normal head circumference and 85 were born with microcephaly (<2 standard deviations below normal). Women with blood Phe >600 micromol/L at 8 weeks of gestation included 78 (92%) of the 85 infants with microcephaly compared with 8% in the group of women who had blood Phe levels < or =600 micromol/L. Weight gain during pregnancy was related to the rate of microcephaly. The highest occurrence of microcephaly (58%) was found in the pregnant women who gained <70% of recommended weight gain. Stepwise logistic regression analysis was used to determine factors associated with microcephaly. Significant factors included higher blood Phe levels when off diet, higher average Phe exposure during the pregnancy, low prepregnancy weight, poor weight gain during the pregnancy, and lower intake of protein and higher iron intake during the pregnancy. Infants with CHD were found only in the group of women who had blood Phe levels >600 micromol/L by 8 weeks of gestation. There was a higher rate of CHD in the offspring who were born to women who consumed <50% of the recommended intake of protein in the first trimester. The main source of protein for women with PKU is the medical food; therefore, when protein intake was low, vitamin and mineral intakes were also inadequate.
The data indicate that blood Phe control and how soon it is attained during pregnancy with PKU is important. Normal pregnancy weight gain should be encouraged to reduce microcephaly. Adequate protein and vitamin intakes early in pregnancy may have a protective effect for the prevention of CHD, even if blood Phe is elevated. The rate of microcephaly and CHD may be reduced if nutrient intake is optimal while attempting to control blood Phe levels.
母体苯丙酮尿症(PKU)综合征是由孕期血液中苯丙氨酸(Phe)水平过高引起的,会导致一系列出生缺陷,尤其是小头畸形和先天性心脏病(CHD)。为了探究母体PKU综合征是否可以预防,组织了一项国际合作研究来评估采用限制苯丙氨酸饮食进行治疗的效果。评估孕期血液苯丙氨酸水平、母体体重增加及营养摄入对后代小头畸形和先天性心脏病发生率的影响。
该研究是一项前瞻性纵向研究,旨在降低孕期血液苯丙氨酸水平。妇女在转诊妊娠时入组。本报告所依据的营养摄入分析数据来自251例妊娠。根据妊娠8周时血液苯丙氨酸控制水平分层:≤600微摩尔/升或>600微摩尔/升。这些妊娠的结局与血液苯丙氨酸水平、体重增加及营养摄入相关。
研究目标是在受孕前3个月将血液苯丙氨酸水平维持在120至360微摩尔/升;然而,只有少数患者实现了这一目标。因此,所呈现的数据基于妊娠8周时血液苯丙氨酸控制水平≤600微摩尔/升或>600微摩尔/升。本研究中251名妇女中有86名(34.3%)在妊娠8周时血液苯丙氨酸控制水平≤600微摩尔/升,而另外165名妇女在妊娠8周时血液苯丙氨酸控制水平>600微摩尔/升。在251名后代中,166名出生时头围正常,85名出生时患有小头畸形(低于正常2个标准差)。妊娠8周时血液苯丙氨酸>600微摩尔/升的妇女所生的85名小头畸形婴儿中有78名(92%),而血液苯丙氨酸水平≤600微摩尔/升的妇女组中这一比例为8%。孕期体重增加与小头畸形发生率相关。体重增加未达到推荐量70%的孕妇中,小头畸形发生率最高(58%)。采用逐步逻辑回归分析来确定与小头畸形相关的因素。显著因素包括非饮食状态下血液苯丙氨酸水平较高、孕期平均苯丙氨酸暴露量较高、孕前体重低、孕期体重增加不佳以及孕期蛋白质摄入量较低和铁摄入量较高。先天性心脏病婴儿仅在妊娠8周时血液苯丙氨酸水平>600微摩尔/升的妇女组中发现。孕早期蛋白质摄入量低于推荐量50%的妇女所生后代中先天性心脏病发生率较高。患有PKU的妇女蛋白质的主要来源是医用食品;因此,当蛋白质摄入量低时,维生素和矿物质摄入量也不足。
数据表明,孕期母体PKU血液苯丙氨酸控制情况以及控制的及时性很重要。应鼓励孕期体重正常增加以减少小头畸形。即使血液苯丙氨酸水平升高,孕早期充足的蛋白质和维生素摄入可能对预防先天性心脏病有保护作用。在试图控制血液苯丙氨酸水平的同时,如果营养摄入最佳,小头畸形和先天性心脏病的发生率可能会降低。